Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metapneumovirus Infection”

24 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 24 results

Early research (Phase 1)Study completedNCT06604767
What this trial is testing

Study of a Respiratory Syncytial Virus/Human Metapneumovirus/Parainfluenza Virus Type 3 Vaccine Candidate in Adults Aged 60 Years and Older

Who this might be right for
Respiratory Syncytial Virus InfectionMetapneumovirus InfectionParainfluenzae Virus Infection
Sanofi Pasteur, a Sanofi Company 390
Not applicableStudy completedNCT01302418
What this trial is testing

Collection and Testing of Respiratory Samples

Who this might be right for
QIAGEN ResPlex II Advanced PanelInfluenza ARespiratory Syncytial Virus Infections+15 more
QIAGEN Gaithersburg, Inc 272
Early research (Phase 1)Study completedNCT03392389
What this trial is testing

Safety, Reactogenicity, and Immunogenicity of mRNA-1653 in Healthy Adults

Who this might be right for
Human Metapneumovirus and Human Parainfluenza Infection
ModernaTX, Inc. 124
Not applicableNot Yet RecruitingNCT06764381
What this trial is testing

Study of Viral Respiratory Infections

Who this might be right for
Respiratory Infections
IRCCS Azienda Ospedaliero-Universitaria di Bologna 20,000
Early research (Phase 1)Study completedNCT06583031
What this trial is testing

Study to Evaluate the Safety and Immune Response of an Investigational Vaccine for the Prevention of RSV (Respiratory Syncytial Virus) and (hMPV) Human Metapneumovirus Infection in Participants Aged 60 to 75 Years

Who this might be right for
RSV InfectionhMPV
Sanofi Pasteur, a Sanofi Company 385
Not applicableEnded earlyNCT04431050
What this trial is testing

Evaluation of a Single Use Point of Care Device for the Diagnosis of Respiratory Pathogens

Who this might be right for
Human InfluenzaRespiratory Syncytial Virus InfectionsRhinoviral Infections+3 more
Imperial College London 6
Not applicableStudy completedNCT03574532
What this trial is testing

Determine the Epidemiology and Evaluate the Burden of Disease in Respiratory Syncytial Virus/Human Metapneumovirus and Influenza A Infected Hospitalized Participants (Adults and Children)

Who this might be right for
Respiratory Tract Infections
Janssen-Cilag International NV 118
Not applicableUnknownNCT03460171
What this trial is testing

Clinical Features, Outcome and Prognosis of Human Metapneumovirus (hMPV) Lower Respiratory Tract Infections in Adult Inpatients

Who this might be right for
Lower Resp Tract InfectionHuman Metapneumovirus Infection
Assistance Publique - Hôpitaux de Paris 400
Not applicableStudy completedNCT00265187
What this trial is testing

The Prevalence and Clinical Manifestations of Human Metapneumovirus Among Children With Bronchiolitis.

Who this might be right for
Respiratory Tract InfectionChildren
HaEmek Medical Center, Israel 200
Early research (Phase 1)Study completedNCT06237296
What this trial is testing

Study of the Safety and Immune Response of an Investigational mRNA Vaccine for the Prevention of Respiratory Syncytial Virus and/or Human Metapneumovirus in Participants Aged 18 to 49 Years and 60 Years and Older

Who this might be right for
Respiratory Syncytial Virus InfectionHealthy VolunteersMetapneumovirus Infection
Sanofi Pasteur, a Sanofi Company 558
Testing effectiveness (Phase 2)Study completedNCT06134648
What this trial is testing

Study of a Respiratory Syncytial Virus/Human Metapneumovirus Vaccine Candidate

Who this might be right for
Respiratory Syncytial Virus InfectionHealthy VolunteersHuman Metapneumovirus
Sanofi Pasteur, a Sanofi Company 646
Testing effectiveness (Phase 2)Active Not RecruitingNCT06984094
What this trial is testing

Safety and Immunogenicity Study of SCB-1022 and SCB-1033 in Healthy Older Adults

Who this might be right for
RSV InfectionHuman Metapneumovirus InfectionParainfluenza Infection
Clover Biopharmaceuticals AUS Pty 612
Testing effectiveness (Phase 2)Ended earlyNCT04933968
What this trial is testing

Study of ALVR106 in Patients With Respiratory Viral Infections After Hematopoietic Cell and Solid Organ Transplant

Who this might be right for
Respiratory Tract Viral InfectionsHuman Metapneumovirus (hMPV) InfectionParainfluenza (PIV) Infection+2 more
AlloVir 17
Early research (Phase 1)Active Not RecruitingNCT04896853
What this trial is testing

Treatment of Respiratory Complications Associated With COVID19,Influenza ,Metapneumovirus,RSV Infection Using ProTrans®

Who this might be right for
COVID-19 Acute Respiratory Distress SyndromeInfluenza AMetapneumovirus Pneumonia+1 more
NextCell Pharma Ab 9
Not applicableActive Not RecruitingNCT05864118
What this trial is testing

Comparison of Nasopharyngeal Swab v. Nasopharyngeal Saline Wash or Saliva Collection in Testing for Respiratory Viruses

Who this might be right for
Respiratory Tract Infections
University of Nebraska 1,000
Not applicableUnknownNCT00613184
What this trial is testing

Comparison of Nylon Flocked Swabs and Saline Aspirates for Detection Respiratory Viruses

Who this might be right for
Respiratory Syncytial VirusHuman MetapneumovirusInfluenza+2 more
Kern Medical Center 150
Not applicableNot Yet RecruitingNCT07599449
What this trial is testing

Virological Surveillance of Acute Respiratory Infection in Primary Health Care in Metropolitan France

Who this might be right for
Respiratory Tract Infections (RTI)Influenza -Like IllnessInfluenza+4 more
Institut National de la Santé Et de la Recherche Médicale, France 25,000
Testing effectiveness (Phase 2)Looking for participantsNCT06999603
What this trial is testing

Phase 2 Study of Inhaled SNG001 in Mechanically Ventilated Patients With Respiratory Viral Infection

Who this might be right for
Viral Pneumonia
Synairgen Research Ltd. 550
Early research (Phase 1)Study completedNCT06850051
What this trial is testing

A Study on the Safety and Immunogenicity of Influenza, Respiratory Syncytial Virus, Human Metapneumovirus and Parainfluenza Vaccines in Adults 18 to 49 Years of Age.

Who this might be right for
Healthy VolunteersInfluenza VaccinationRespiratory Syncytial Virus Vaccination+2 more
Sanofi 270
Testing effectiveness (Phase 2)Active Not RecruitingNCT06686654
What this trial is testing

Study of a Human Metapneumovirus/Respiratory Syncytial Virus mRNA Vaccine Candidate Encapsulated in a Lipid Nanoparticle-based Formulation in Adults Aged 60 Years and Older

Who this might be right for
Human Metapneumovirus ImmunizationRespiratory Syncytial Virus Immunization
Sanofi Pasteur, a Sanofi Company 1,530
Load More Results